However, all students are required to fill out the Immunization form with their history of vaccinations already taken. If proof of primary series cannot be furnished, then a positive titer will ...

The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.

responses to the tetanus vaccine was similar in both groups—39.1% of rituximab-treated patients had a 4-fold or greater increase in anti-tetanus immunoglobulin G titers from baseline compared ...

All students born in the U.S. after 1/1/1957 must show evidence of immunity to Measles, Mumps and Rubella as below: Documentation of vaccination with 2 doses of live mumps virus-containing vaccine, or ...

QIV was immunogenic against all 4 vaccine strains and 87.0%, 88.6%, 69.8% and 97.9% of children had postvaccination titers of ≥1:40 against A/H1N1, A/H3N2, B/Victoria and B/Yamagata, respectively.

The issuer is solely responsible for the content of this announcement.

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus (CHIKV) vaccine in adolescents.

In low risk children initially receiving a recombinant vaccine, 12.5% (26 of 208) and none (0 of 36) retained protective anti-HBs titers at 5 and 7 years of age, respectively. Of those who did not ...